Clinical Trials Logo

Filter by:
NCT ID: NCT04017845 Completed - Colorectal Cancer Clinical Trials

Screening for Colorectal Cancer in Average and High Risk Population

Start date: April 1, 2015
Phase: Early Phase 1
Study type: Interventional

The existing evidence from epidemiological studies and randomized controlled trials has consistently assures the cost effectiveness and the influential role of screening in reducing incidence rates and deaths caused by Colorectal Cancer (CRC). Population based organized screening programmes, which should be considered an obligation that is not to be postponed, require valuable information that can be reliably extrapolated from well-designed pilot study conducted prior to programme implementation. The main objectives of the current pilot CRC screening project, named after "Al-Kindy College of Medicine", was to evaluate and explore the specific aspects of the intended population-based organized CRC screening programme, including: barriers affecting adherence to the programme, performance indicators of the proposed screening programme, the target population in which CRC screening is a legitimate healthcare priority, quality assurance of screening tests and colonoscopy services, and to propose an algorithm that will provide a clinically and logistically acceptable positivity rate.

NCT ID: NCT03946813 Completed - Infertility, Female Clinical Trials

The Efficacy of Platelets Rich Plasma for Ovarian Rejuvenation

Start date: August 20, 2018
Phase: N/A
Study type: Interventional

In recent years, an increased approach has appeared in the use of autologous blood products to assist tissue and organ healing. Application of platelet rich plasma (PRP) has emerged as a potential solution for infertile women with poor ovarian reserve in reproductive specialty.

NCT ID: NCT03946163 Completed - Clinical trials for Chronic Pelvic Pain Syndrome

The Effect of Cinnamon on Patients With Chronic Prostatitis/Chronic Pelvic Pain Syndrome; a Pilot Study

Start date: February 1, 2018
Phase: Early Phase 1
Study type: Interventional

Chronic prostatitis / chronic pelvic pain syndrome (CP/CPPS) is one of the common urologic problems, nevertheless; its etiology and pathophysiology are poorly understood, with no solid guidelines for effective treatment. The beneficial health attributes of cinnamon and its derivative and components were reported by several researchers, this study is designed to illuminate the possible benefits of cinnamon on patients with Chronic prostatitis / chronic pelvic pain syndrome (CP/CPPS)

NCT ID: NCT03850561 Completed - Male Infertility Clinical Trials

Effect of Two Doses of Coenzyme Q10 on Seminal Fluid and Semen Antioxidant Status

Start date: June 1, 2018
Phase: N/A
Study type: Interventional

The study was conducted to assess the impact of two doses of coenzyme Q10 on seminal fluid parameters and antioxidant status in infertile men.

NCT ID: NCT03834831 Completed - Male Infertility Clinical Trials

Impact of Coenzyme Q10 and Selenium on Seminal Fluid and Semen Antioxidant Status

Start date: June 1, 2018
Phase: N/A
Study type: Interventional

The study was conducted to assess the impact of coenzyme Q10 and selenium on seminal fluid parameters and antioxidant status in infertile men.

NCT ID: NCT03790904 Completed - Clinical trials for Periodontal Diseases

Anti Plaque Efficacy of Salvadora Persica L. and Green Tea Mouthwash

Start date: January 10, 2019
Phase: Phase 2
Study type: Interventional

Periodontal diseases and caries are essentially initiated and progressed by accumulation of dental plaque. Thus, daily effective plaque control is valuable as a preventive measure and maintaining oral health. Mechanical plaque control is important but has limitations; therefore, an adjunctive chemical plaque control such as mouthwash is helpful. Various medicinal plant-derived galenicals might be used as safe and stable alternatives to synthetic mouthwashes. For example, a combination of Salvadora persica L. (Sp) root sticks and green tea (Gt) aqueous extract has been found to reduce plaque accumulation over 24 hours. Moreover, these extracts were reported to have anti-microbial activity against many oral bacteria. The objective of this study was to investigate the efficacy of the combination of Gt aqueous extract and Sp aqueous extract in reducing plaque buildup for 4 days duration.

NCT ID: NCT03755531 Completed - Clinical trials for Postpartum Hemorrhage (Primary)

Carbetocin Versus Oxytocin for the Prevention of Postpartum Hemorrhage in Emergency Caesarean Delivery

Start date: January 4, 2018
Phase: Phase 4
Study type: Interventional

Postpartum haemorrhage keeps to be the leading cause of maternal mortality in middle and low-income countries, including Iraq. Much advancement had been made in the field of treatment for postpartum haemorrhage but no much progress had been made in the field of prevention, where one of its main component is the administration of uterotonic, preferably oxytocin, immediately after birth of the baby. In many low- and middle income countries, the efficacy of oxytocin cannot be assured since access to sustained cold-chain is unavailable. Regarding the other uterotonics; ergometrine degrades when exposed to heat or light. Misoprostol degrades rapidly when exposed to Moisture. Innovation in the manufacture of carbetocin had meet the stability requirements for hot and humid climates. This study had been accomplished to evaluate the uterotonic effect of carbetocin compared with oxytocin for the prevention of postpartum haemorrhage in emergency caesarean delivery. Looking if carbetocin is superior to oxytocin in term of reduction in the need for additional uterotonic agents or the occurrence of PPH.

NCT ID: NCT03632824 Completed - Clinical trials for Vaginal Bleeding During Pregnancy

Tranexamic Acid in Pregnancies With Vaginal Bleeding

Start date: February 1, 2016
Phase: N/A
Study type: Interventional

Tranexamic acid has been proposed and used for prevention and management of antepartum and postpartum hemorrhage.

NCT ID: NCT03615534 Completed - Clinical trials for Obesity Associated Disorder

Extended Release Niacin and Fenofibrate for the Treatment of Atherogenic Dyslipidemia in Obese Females

Start date: October 1, 2014
Phase: Phase 4
Study type: Interventional

Atherogenic Dyslipidemia (AD) is a risk-conferring lipid/lipoprotein profile that comprises a higher proportion of small LDL particles, reduced HDL-C, and increased triglycerides. It is characteristically seen in patients with obesity, metabolic syndrome, insulin resistance, and type 2 diabetes mellitus and has emerged as an important marker for the increased cardiovascular disease (CVD) risk observed in these populations. Optimal cardiovascular risk reduction in patients exhibiting the lipid triad of AD requires integrated pharmacotherapy to normalize HDL-C, Triglyceride (TG) and LDL-C levels. Recent studies have focused on optimizing treatment for AD and compare the efficacy and tolerability of combined lipid-altering drug based therapies, however, an optimal pharmacologic approach has not yet been established. The present study was intended to evaluate the restorative efficacy of Extended Release Niacin (ER Niacin) and Fenofibrate as mono and combination therapies , as well as their safety and tolerability in females with obesity-induced AD.

NCT ID: NCT03601338 Completed - Clinical trials for Unexplained Stillbirth

Low Molecular Weight Heparin in Pregnancies With Unexplained Stillbirths

Start date: August 1, 2015
Phase: Early Phase 1
Study type: Interventional

Bemiparin for pregnant women with abnormal umbilical artery Doppler ultrasound